Roche
-
Potential losses exceed $300 billion! Nearly 200 drugs are facing a patent cliff
For more reports, please follow DrugTimes
-
【Product for Licensing】siRNA Therapeutics Targeting AGT for Hypertension
If you are interested in this asset or need more information, please kindly contact DrugTimes BD Team at BD@drugtimes.cn, we will present the non-confidential deck to you for review asap. Many thanks!~
-
Shocking! Genentech is set to close its cancer immunology research department, and star scientists are resigning
Welcome friends to leave a message in the comments section!
-
Roche’s bispecific antibody therapy sets a new record as the “king of drugs” in ophthalmology
DrugTimes Team will follow up on this subject. Please stay tuned
-
Morphic’s stock prices soar by 75%! Eli Lilly invests an additional $3.2 billion in the autoimmune field
DrugTimes will present more reports timely. Please stay tuned
-
【Product Wanted】HER2 Small Molecules That Can Penetrate BBB
If interested, please contact DrugTimes BD Team at BD@drugtimes.cn
-
Ascidian Therapeutics Enters Collaboration with Roche for Discovery and Development of RNA Exon Editing Therapeutics Targeting Neurological Diseases
Congratulations to Roche and Ascidian Therapeutics!
-
TOP PHARMAS BY 2024 PIPELINE SIZE
For more info, please visit https://www.drugtimes.cn/english-content
-
齐碳科技发布国产首台四代基因测序仪，为中国基因测序市场加码
原文始发于微信公众号（药时代）：齐碳科技发布国产首台四代基因测序仪，为中国基因测序市场加码 ⬆️欢迎走进博腾药时代直播间！ 2020年9 月 21 日，齐碳科技有限公司（以下简称“…
